The use of r-hFSH in treatment of idiopathic male factor infertility before ICSI

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 12, 2015, Pages 2162-2167

  Farrag, A ^a   Sagnella, F ^a   Pappalardo, S ^a   Costantini, A ^a   Lisi, F ^b   Carfagna, P ^b   Manna, C ^a  

^a Biofertility IVF Center   (Italy)

^b IVF   (Italy)

Author keywords

FSH therapy; ICSI; Idiopathic male factor infertility

Indexed keywords

RECOMBINANT FOLLITROPIN; FOLLITROPIN; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERTILIZATION; HUMAN; IDIOPATHIC DISEASE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OLIGOSPERMIA; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; DRUG EFFECTS; FERTILIZATION IN VITRO; INFERTILITY, MALE; NIDATION; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; PROCEDURES; SPERMATOZOON COUNT; TREATMENT OUTCOME; TRENDS;

ADULT; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; INFERTILITY, MALE; MALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; SPERM COUNT; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 84942253645     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. MEACHAM RB, LIPSHULTZ LI, HOWARDS SS. MALE INFERTILITY. IN: Gillenwater JY, Grayhack JT, Howards SS, Duckett JW, editor (s). Adult and pediatric Urology. St Louis: Mosby-Year Book Inc, 1996; pp. 1747-802.
2. WORLD HEALTH ORGANIZATION. WHO: Towards more objectivity in diagnosis and management of male infertility. Results of aWorld Health Organization multicentre study. Int J Androl 1987;10(Suppl 7):1-35.
3. IRVINE DS. Epidemiology and aetiology of male infertility. Hum Reprod 1998;13(Suppl 1):33-44.
4. LOPES S, GUO SUN J, JURISICOVA A, MERIANO J, CASPER RF. Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection. Fertil Steril 1998;69:528-532.
5. SAKKAS D, URNER F, BIANCHI PG, BIZZARRO D, WAGNER I, JAQUENOUD N, MANICARDI G, CAMPANA A. Sperm chromatin anomalies can infeluence decondansation after intracytoplasmic sperm injection. Hum Reprod 1996;11:837-843.
6. SAKKAS D, URNER F, BIZZARRO D, MANICARDI G, BIANCHI PG, SHOUKIL Y, CAMPANA, A. Sperm nuclear DNA damage and altered chromatin structure: effect on fertilization and embryo development. Hum Reprod 1998;13:11-19.
7. MATSUMOTO AM. Hormonal control of human spermatogenesis. In: Burger H, de Kretser D, eds. Thetestis. New York: Raven Press, 1989; pp. 181-196.
8. SHARPE RM. Follicle-stimulating hormone and spermatogenesis in adult male. J Endocrinol 1989;121:405-407.
9. ACOSTA AA, KHALIFA E, OEHNINGER S. Pure human follicle stimulating hormone has a role in treatment of sever male infertility by assisted reproduction: Norfolk's total experience. Hum Reprod 1992;7:1067-1072.
10. BARTOOV B, ELTES F, LUNENFELD E. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertil Steril 1994;61:727-734.
11. WORLD HEALTH ORGANIZATION. Laboratory manual for the examination of human semen and spermcervical mucus interaction. Cambridge (UK): Cambridge University Press, 1999.
12. PALERMO G, JORIS H, DEVROEJ P, VAN STEIRTEGEM AC. Pregnancies after intracytoplasmic injection of a single spermatozoon into an oocyte. Lancet 1992;340:17-18.
13. VAN STEIRTEGHEM AC, NAGY Z, JORIS H, LIU J, STAESSEN C, SMITZ J, WISANTO A AND DEVROEY P. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod 1993;8:1061-1066.
14. WEINBAUER GF, GROMOLL J, SIMONI M, NIESCHLAG E. PHYSIOLOGY OF TESTICULAR FUNCTION. IN: NIESCHLAG E, BEHRE HM, EDS. Andrology. Male reproductive health and dysfunction. New York: Springer-Verlag, 1997; pp. 25-57.
15. TAPANAINEN JS, AITTOMAKI K, MIU J, VASKIVUO T, HUTTANIEMI JT. Men homozygous for an inactive mutation of the follicle stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997;15:205-206.
16. PHILIP M, ARBELLE JE, SEGEV Y, PARVARI R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 1998;338:500-501.
17. FORESTA C, BETTELLA A, MERICO M, GAROLLA A, PLEBANI M, FERLIN A, ROSSATO M. FSH in the treatment of oligozoospermia. Mol Cell Endocrinol 2000;161:89-97.
18. BEN-RAFAEL Z, FARHI J, FELDBERG D, BARTOOV B, KOVO M, ELTES F, ASHKENAZI J. Follicle-stimulating hormone treatment for men with idiopathic oligoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertil Steril 2000;73:24-30.
19. FORESTA C, BETTELLA A, MERICO M, GAROLLA A, FERLIN A ROSSATO M. Use of recombinant human folliclestimulating hormone in the treatment of male factor infertility. Fertli Steril 2002;77:238-244.
20. CAROPPO E, NIEDERBERGER C, VIZZIELLO GM, D'AMATO G. Recombinant human follicle-stimulating hormone as a pre-treatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertil Steril 2003;80:1398-1403.
21. STREHLER E, STERZIK K, DE SANTO M, ABT M, WIEDEMANN R, BELLATI U, COLLODEL G, PIOMBONI P, BACCETTI B. The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. J Androl 1997;18:439-447.
22. FORESTA C, BETTELLA A, GAROLLA A, AMBROSINI G, FERLIN A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertil Steril 2005;84:654-661.
23. ASHKENAZI J BAR-HAVA I, FARHI J, LEVY T, FELDBERG D, ORVIETO R, BEN-RAFAEL Z. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertil Steril 1999;72:670-673.